10xBio Announces the Completion of Phase 1B Clinical Trial of 10XB101

10xBio Announces the Completion of Phase 1B Clinical Trial of 10XB101 May 6, 2019 SAN DIEGO (May 6, 2019) – 10xBio, LLC, a privately-held biotechnology company, announced today that it has completed a Phase 1B study of its novel injectable drug product for body...

10xBio Completes Series A Financing

10xBio Completes Series A Financing April 2, 2018 SAN DIEGO (April 2, 2018) – 10xBio, LLC, a privately-held biotechnology company, completed a Series A financing from a select group of partners and private investors during the first quarter of 2018. Capital raised...

10xBio Announces Issuance of U.S. Patent

10xBio Announces Issuance of U.S. Patent May 31, 2017 SAN DIEGO (May 31, 2017) – 10xBio, LLC, a privately-held biotechnology company, announced today that it has been issued patent 9,351,945 from the U.S. Patent and Trademark Office. The patent broadly covers...